The interaction of FK409, a novel nitric oxide releaser, and peripherally administered morphine during experimental inflammation

Anesthesia and Analgesia

Volumn 86, Issue 2, 1998, Pages 367-373

  Nozaki Taguchi, Natsuko ^a   Yamamoto, Tatsuo ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 ETHYL 2 HYDROXYIMINO 5 NITRO 3 HEXENAMIDE; MORPHINE; NALOXONE; NITRIC OXIDE;

AGITATION; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVATION; INFLAMMATION; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG SYNERGISM; FORMALDEHYDE; INFLAMMATION; INJECTIONS, SUBCUTANEOUS; MALE; MORPHINE; NITRIC OXIDE; NITRO COMPOUNDS; PAIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031911904     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199802000-00028     Document Type: Article

References (25)

1. Palmer RMJ, Ferringe AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
2. Bredt DS, Snyder SH. Nitric oxide, a novel neuronal messenger. Neuron 1992;8:3-11.
3. Yamamoto T, Shimoyama N, Mizuguchi T. Nitric oxide synthase inhibitor blocks spinal sensitization induced by formalin injection into the rat paw. Anesth Analg 1993;77:886-90.
4. Kawabata A, Manabe S, Manabe Y, Takagi H. Effect of topical administration of L-arginine on formalin-induced nociception in the mouse: a dual role of peripherally formed NO in pain modulation. Br J Pharmacol 1994;112:547-50.
5. Kawabata A, Fukuzumi Y, Fukushima Y, Takagi H. Antinociceptive effect of L-arginine on the carrageenin-induced hyperalgesia of the rat: possible involvement of central opioidergic systems. Eur J Pharmacol 1992;218:153-8.
6. Kawabata A, Nishimura Y, Takagi H. L-Leucyl-L-arginine, naltrindole and D-arginine block antinociception elicited by L-arginine in mice with carrageenin-induced hyperalgesia. Br J Pharmacol 1992;107:1096-101.
7. Hino M, Iwami M, Okamoto M, et al. FK409, a novel vasodilator isolated from the acid-treated fermentation broth of Streptomyces griseosporeus. I. taxonomy, fermentation, isolation, and physiochemical and biological characteristics. J Antibiot 1989;42: 1578-83.
8. Kita Y, Hirasawa Y, Maeda K, et al. Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409. Eur J Pharamacol 1994;257:123-30.
9. Fukuyama S, Kita Y, Hirayama T, et al. A new nitric oxide (NO) releaser: spontaneous NO release from FK 409. Free Radic Res 1995;23:443-52.
10. Duarte IDG, Lorenzetti BB, Ferreira SH. Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Eur J Pharmacol 1990;186:289-93.
11. Duarte IDG, dos Santos IR, Lorenzetti B, Ferreira SH. Analgesia by direct antagonism of nociceptor sensitization involves the arginine-nitric oxide-cGMP pathway. Eur J Pharmacol 1992;217: 225-7.
12. Duarte IDG, Ferreira SH. The molecular mechanism of central analgesia induced by morphine or carbachol and the L-arginine-nitric oxide-cGMP pathway. Eur J Pharmacol 1992;221:171-4.
13. Brignola G, Calignano A, DiRosa M. Modulation of morphine antinociception in the mouse by endogenous nitric oxide. Br J Pharmacol 1994;113:1372-6.
14. Ferreira SH, Duarte IDG, Lorenzetti BB. The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release. Eur J Pharmacol 1991;201:121-2.
15. Wheeler-Aceto H, Porreca F, Cowan A. The rat paw formalin test: comparison of noxious agents. Pain 1990;30:229-38.
16. Akaie T, Yoshida M, Miyamoto Y, et al. Antagonistic action of imidazolieoxyl N-oxides against endothelium-derived relaxing factor/NO through radical reaction. Biochemistry 1993;32: 827-32.
17. Zar JH. Biostatistical analysis. 2nd ed. Englewood Cliffs, NJ: Prentice Hall, 1984:292-305.
18. Yamamoto T, Yaksh TL. Comparison of antinociceptive effects of pre-and posttreatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat. Anesthesiology 1992;77:757-63.
19. Hong Y, Abhott FV. Peripheral opioid modulation of pain and inflammation in the formalin test. Eur J Pharmacol 1995;277: 21-8.
20. Granados-Soto V, Flores-Murrieta FJ, Castaneda-Hernandez G, Lopez-Munoz FJ. Evidence for the involvement of nitric oxide in the antinociceptive effect of ketorolac. Eur J Pharmacol 1995;277: 281-4.
21. Ferreira SH, Lorenzetti BB, Faccioli LH. Blockade of hyperalgesia and neurogenic oedema by topical application of nitroglycerin. Eur J Pharmacol 1992;217:207-9.
22. Haley JE, Dickenson AH, Schachter M. Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat. Neuropharmacology 1992;31:251-8.
23. Änggard E. Nitric oxide: mediator, murderer, and medicine. Lancet 1994;343:1199-206.
24. Dray A. Inflammatory mediators of pain. Br J Anaesth 1995;75: 125-31.
25. Ialenti A, Ianaro A, Moncada S, DiRosa M. Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol 1992; 211:177-82.